Translating cell and gene therapies to the clinic

Cell Gene Therapy Insights 2018; 4(11), 1059-1072.


Published: 18 December 2018
Expert Insight
Hema Dave, Devin Saunders, Nan Zhang, Patrick J Hanley

The translation of cell and gene therapy products requires significant resources, knowledge, experience, and infrastructure. Even with vast resources, the path forward is often non-linear, confusing, and cumbersome. Here we review the process by which to take a cell or gene therapy product from discovery into a phase 1 clinical trial in the academic setting.

Submitted for peer review: 25 Oct 2018 Published: 19 Dec 2018